/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | BYAHPark Ha Biological T |
|---|---|
| Last close | $2.18close 2026-11-09 |
| Change % | +0.96%close 2026-11-09 |
| Market cap | $64Mclose 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $3M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2025-10-31 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 6.0%FY to 2025-10-31 |
| Net income | $-24364753⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-10-31 Filing20-F/A · 0001213900-26-057152 · filed 2026-05-15 Open the filing on EDGAR →Open the XBRL payload →CitePark Ha Biological Technology Co., Ltd. (BYAH), us-gaap:NetIncomeLoss: -24,364,753 USD, fiscal year ended 2025-10-31. Form 20-F/A, accession 0001213900-26-057152, filed 2026-05-15. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001986247/us-gaap/NetIncomeLoss.json |
| Net margin | -965.0%FY to 2025-10-31 |
| EPS (diluted) | $-41.38⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-10-31 Filing20-F/A · 0001213900-26-057152 · filed 2026-05-15 Open the filing on EDGAR →Open the XBRL payload →CitePark Ha Biological Technology Co., Ltd. (BYAH), us-gaap:EarningsPerShareDiluted: -41.38 USD per share, fiscal year ended 2025-10-31. Form 20-F/A, accession 0001213900-26-057152, filed 2026-05-15. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001986247/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 4FY to 2025-10-31 |
| Altman Z-ScoreUNVALIDATED | 1.71FY to 2025-10-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | — |